TI
GH icon

Trexquant Investment’s Guardant Health GH Stock Holding History

Trexquant Investment’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.93M Sell
85,901
-188,138
-69% -$18.9M 0.06% 460
2025
Q4 		$28M Sell
274,039
-110,691
-29% -$9.9M 0.25% 62
2025
Q3 		$24M Buy
384,730
+8,025
+2% +$437K 0.25% 65
2025
Q2 		$19.6M Buy
376,705
+196,315
+109% +$8.77M 0.22% 95
2025
Q1 		$7.68M Sell
180,390
-293,781
-62% -$12.7M 0.09% 338
2024
Q4 		$14.5M Buy
474,171
+18,461
+4% +$519K 0.17% 166
2024
Q3 		$10.5M Sell
455,710
-129,204
-22% -$3.66M 0.13% 230
2024
Q2 		$16.9M Buy
584,914
+312,418
+115% +$7.27M 0.26% 72
2024
Q1 		$5.62M Buy
272,496
+48,849
+22% +$1.05M 0.11% 261
2023
Q4 		$6.05M Sell
223,647
-4,097
-2% -$107K 0.14% 193
2023
Q3 		$6.75M Sell
227,744
-3,849
-2% -$135K 0.17% 166
2023
Q2 		$8.29M Buy
231,593
+139,384
+151% +$4M 0.22% 100
2023
Q1 		$2.16M Buy
+92,209
New +$2.63M 0.06% 435
2022
Q4 		– Sell
-17,746
Closed -$955K – 1495
2022
Q3 		$955K Buy
+17,746
New +$911K 0.03% 545
2022
Q1 		– Sell
-11,823
Closed -$1.18M – 1489
2021
Q4 		$1.18M Buy
+11,823
New +$1.22M 0.07% 345
2021
Q3 		– Sell
-26,329
Closed -$3.27M – 1271
2021
Q2 		$3.27M Buy
+26,329
New +$3.54M 0.28% 94
2021
Q1 		– Sell
-7,741
Closed -$998K – 1237
2020
Q4 		$998K Buy
+7,741
New +$891K 0.11% 258
2019
Q4 		– Sell
-15,892
Closed -$1.01M – 1120
2019
Q3 		$1.01M Buy
+15,892
New +$1.4M 0.09% 281

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Trexquant Investment's GH Position: Q1 2026 in Review

Trexquant Investment reduced its Guardant Health (GH) stake by 69% in Q1 2026, selling an estimated $18.9M and leaving 85,901 shares worth $7.93M. The position accounts for 0.06% of the portfolio, ranked #460.

Trexquant Investment first reported a position in GH in Q3 2019 and has held it in 18 quarters since. The position peaked at $28M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Trexquant Investment held 85,901 shares of Guardant Health worth $7.93M as of Q1 2026.
  • Trexquant Investment sold 188,138 Guardant Health shares in Q1 2026, an estimated $18.9M.
  • Guardant Health made up 0.06% of Trexquant Investment's portfolio in Q1 2026, its #460 holding.
  • Trexquant Investment first reported a position in Guardant Health in Q3 2019 and has held it in 18 quarters since.
  • Trexquant Investment's Guardant Health position peaked at $28M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.